Term
What is the difference between a professional and non-professional APC? |
|
Definition
professional APC's exress high levels of MHC's and co-stimulatory molecules non-professional APC's express MHC, but in lower levels
|
|
|
Term
| structure of MHC I molecule |
|
Definition
|
|
Term
| Describe the action of nonclassical MHC molecules. Give examples. |
|
Definition
|
|
Term
| MHC I: role of anchoring residues, where these residues are found, and their general length |
|
Definition
|
|
Term
| MHC II: role of anchoring residues, location, and general length |
|
Definition
|
|
Term
| Sometimes MHC molecules can present different peptides to a TCR, but there is no activation of the T cell. Why is that? |
|
Definition
| T cell reaction/activation is all based on the type of TCR. |
|
|
Term
| MHC I recognizes what TCR's? MHC II recognizes what TCR's? |
|
Definition
|
|
Term
| types of antigens recognized by MHC I? MHC II? |
|
Definition
|
|
Term
| Pathway of MHC I presentation |
|
Definition
MHC I complexed with calnexin Calnexin is removed and is replaced by Tapsain, calrecticulin, and beta globulin protein protesome degrade peptide peptide binds, leading to exit of calrecticulin and tapsain MHC I exit rER via TAP transporter
|
|
|
Term
| Function of calnexin and calreticulin in MHC I presentation |
|
Definition
| both act as chaperones for MHC I |
|
|
Term
| Function of TAP transporter in MHC I presentation |
|
Definition
| transport peptide into ER from proteosome (channel) |
|
|
Term
| Function of proteosome in MHC I pathway |
|
Definition
| break down antigen into small peptides that attach to MHC I |
|
|
Term
| What pathology results if someone is deficient in TAP? What is the major complication of this pathology? |
|
Definition
if you have no TAP, it leads to bare lymphocyte syndrome complication- patient more susceptible to viruses
|
|
|
Term
| Pathway for MHC II antigen presentation |
|
Definition
invariant chain binds in the groove of the MHC II leaves the ER CLIP will enter after digested invariant chain leaves CLIP is released so endosomal material can enter binding site
|
|
|
Term
| Structure of MHC II molecule |
|
Definition
|
|
Term
| Function of HLA-DM in MHC II presentation |
|
Definition
| cause substitution of CLIP with endosomal material |
|
|
Term
| Function of CLIP in MHC II presentation |
|
Definition
| stays in the groove to stabilize secondary structure of MHC II |
|
|
Term
| What is the disadvantage of having non-professional APC's infected with a virus? |
|
Definition
| If the virus only goes to non-professional APC's, you will never get an immune response from the T cells. |
|
|
Term
Explain the phenomenon of cross presentation of antigens. What is the advantage of this phenomenon? |
|
Definition
after entering MHC II pathway, peptide is divereted from endosomal compartment into the proteosome, leading to it going down the MHC I pathway it presents antigens from avoiding the immune system (some viruses have evolved ways to block entrance into endosomal compartments of the cell)
|
|
|
Term
| Most of the peptides found on MHC molecules are self or non-self? |
|
Definition
|
|
Term
| Different genetic types of MHC I and MHC II (name the subtype that is most diverse) |
|
Definition
|
|
Term
MHC gene locus is located in what chromosome |
|
Definition
| chromosome 6 (called immune response genes cause they are big in regulating antigen recognition and lymphocyte response) |
|
|
Term
| How is MHC diversity mediated since it is a fixed genome? |
|
Definition
|
|
Term
| What components of the MHC rxn do polymorphic MHC complexes affect? |
|
Definition
|
|
Term
| Define allorecognition. What clinical pathology is this seen in? |
|
Definition
SEEN IN REJECTION OF ORGANS!!!! |
|
|
Term
| Since DRβ MHC II molecules are the most diverse type, what is it clinical used in? |
|
Definition
| beta chains used in testing organs prior to transplantation |
|
|
Term
| What type of cells express MHC I? MHC II? |
|
Definition
|
|